Tuesday, February 22, 2011

your patient with parkinson's disease is taking metoclopramide for GERD.?

Which statement is incorrect. a. The frequency of metoclopramide cause extrapyramidal symptoms and depression are higher among those with a history of mental illness, children older ans. b. This medicine may cause drowsiness, confusion, depression c. This drug is the first line of treatment for GERD. d. the drug should be used cautiously in people with Parkinson's disease by blocking dopamine receptors and may worsen the symptoms of PD. c. Dopamine agonists are rarely used for more Parkinson's disease. They are mainly used as antipsychotic agents for PD. Certainly not a first-line drug for GERD in patients with PD. Who said there could be some benefit to the action of metoclopramide in case of digestive problems common in PD and increases muscle contraction of the gastrointestinal tract. a) b) is also a warning of caution) is another warning about the antagonists of dopamine, on dopamine receptors, but does not stimulate, because PD medication (interaction) of these patients is unknown in question statemtment also true. Take a look at this list, if there is additional information about the answer. http://www3.interscience.wiley.com/journal/118506024/abstract?CRETRY=1&SRETRY=0 Although there is a reason for the prescription may be, it would never be a first line treatment for PD to be patient, as defined in the question. dopamine antagonists cause Parkinson-like symptoms. The correct answer is D. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017854s052, D. 021793s005medguide.pdf that this drug certainly aggravates symptoms of what you have. I was prescribed metoclopramide to accelerate the digestion of food, but I had a dystonic reaction, involuntary movements of muscles of the tongue and lower jaw included. The worst feeling you could imagine the fear that he could not talk if I went to the emergency room and received an injection of Benadryl to relax and remove. I know you do not even use this drug more .

0 comments:

Post a Comment